NovoLog PenFill and Ranibizumab
Determining the interaction of NovoLog PenFill and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Ranibizumab Intraocular
- NovoLog PenFill-Ranibizumab ophthalmic
- NovoLog PenFill-Ranitidine
- NovoLog PenFill-Ranitidine Capsule
- NovoLog PenFill-Ranitidine Hydrochloride
- NovoLog PenFill-Ranitidine Injection
- Ranibizumab-Novoseven
- Ranibizumab-NovoSeven RT
- Ranibizumab-NovoSeven RT with MixPro injection
- Ranibizumab-Novothyrox
- Ranibizumab-Noxafil
- Ranibizumab-Noxafil (Posaconazole Delayed-Release Tablets)